BiotechTube
NanoEngineering Corp.

NanoEngineering Corp.

San Diego, United States· Est.
nanoengineeringcorp.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18.2M

Overview

NanoEngineering Corp. is a private, pre-revenue instrumentation company developing and commercializing high-resolution nanoparticle sizing and separation platforms based on Differential Mobility Analysis (DMA). Its core technology enables precise characterization of aerosols and nanoparticles, with immediate applications in bioprocessing, gene therapy development, and structural biology research, as evidenced by recent NIH SBIR/STTR grants. The company operates as a platform technology provider, selling instruments and collaborating with academic and industrial partners to address analytical challenges in life sciences and beyond.

Drug DeliveryMedical Devices

Technology Platform

Proprietary high-resolution Differential Mobility Analysis (DMA) with bipolar nano-electrospray technology for gentle separation and sizing of nanoparticles and aerosols.

Funding History

2
Total raised:$18.2M
Series A$15M
Seed$3.2M

Opportunities

The rapid growth of the gene therapy and viral vector manufacturing market creates a strong demand for advanced analytical tools for quality control, where NanoEngineering's high-resolution sizing technology offers a compelling solution.
Expansion into structural biology through the integration of DMA with cryo-EM represents a potentially disruptive application that could open a new, high-value market segment for the company.

Risk Factors

The company faces significant market adoption risk, as it must convince biopharma labs to switch from established particle analysis methods to its newer technology.
Its reliance on non-dilutive NIH grants for funding, while beneficial for R&D, may not provide sufficient capital for full commercial scale-up, marketing, and sales force development needed to compete effectively.

Competitive Landscape

NanoEngineering competes with large, established analytical instrument companies like Malvern Panalytical (Zetasizer) and TSI Inc., which offer broader suites of particle characterization tools. It also faces competition from other niche DMA manufacturers and alternative technologies like analytical ultracentrifugation and field-flow fractionation used for nanoparticle analysis in biopharma.

More companies in Diagnostics & Precision Medicine →More companies in United States →